FI106260B - Menetelmä verisuonia laajentavien tiatsolidinonin ja oksatsolidinonin johdannaisten valmistamiseksi - Google Patents
Menetelmä verisuonia laajentavien tiatsolidinonin ja oksatsolidinonin johdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI106260B FI106260B FI921340A FI921340A FI106260B FI 106260 B FI106260 B FI 106260B FI 921340 A FI921340 A FI 921340A FI 921340 A FI921340 A FI 921340A FI 106260 B FI106260 B FI 106260B
- Authority
- FI
- Finland
- Prior art keywords
- group
- groups
- carbon atoms
- formula
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 18
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 210000004204 blood vessel Anatomy 0.000 title 1
- 230000000916 dilatatory effect Effects 0.000 title 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract 24
- 150000001875 compounds Chemical class 0.000 claims abstract 22
- 125000000217 alkyl group Chemical group 0.000 claims abstract 21
- 150000003839 salts Chemical class 0.000 claims abstract 16
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract 9
- 125000002947 alkylene group Chemical group 0.000 claims abstract 6
- 125000003118 aryl group Chemical group 0.000 claims abstract 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 29
- 239000003153 chemical reaction reagent Substances 0.000 claims 15
- 125000001424 substituent group Chemical group 0.000 claims 11
- 229910052717 sulfur Inorganic materials 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 8
- 125000004434 sulfur atom Chemical group 0.000 claims 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 5
- 125000002541 furyl group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 125000001544 thienyl group Chemical group 0.000 claims 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 125000003884 phenylalkyl group Chemical group 0.000 claims 2
- 239000011593 sulfur Substances 0.000 claims 2
- MWVNPEVJWHMMFV-UHFFFAOYSA-N 2-[(2-oxo-1,3-oxazolidine-4-carbonyl)amino]ethyl nitrate Chemical compound [O-][N+](=O)OCCNC(=O)C1COC(=O)N1 MWVNPEVJWHMMFV-UHFFFAOYSA-N 0.000 claims 1
- WSPFZJVPRYXFFX-UHFFFAOYSA-N 2-[(2-oxo-1,3-thiazolidine-4-carbonyl)amino]ethyl nitrate Chemical compound [O-][N+](=O)OCCNC(=O)C1CSC(=O)N1 WSPFZJVPRYXFFX-UHFFFAOYSA-N 0.000 claims 1
- SZNHDFQTDIMGRV-UHFFFAOYSA-N 2-[(2-oxo-1,3-thiazolidine-5-carbonyl)amino]ethyl nitrate Chemical compound [O-][N+](=O)OCCNC(=O)C1CNC(=O)S1 SZNHDFQTDIMGRV-UHFFFAOYSA-N 0.000 claims 1
- IVAGZWHXWLCLSB-UHFFFAOYSA-N 2-[(5-benzyl-2-oxo-1,3-thiazolidine-4-carbonyl)amino]ethyl nitrate Chemical compound [O-][N+](=O)OCCNC(=O)C1NC(=O)SC1CC1=CC=CC=C1 IVAGZWHXWLCLSB-UHFFFAOYSA-N 0.000 claims 1
- YFGQVZFEOCXAEE-UHFFFAOYSA-N 2-[[4-(4-methoxyphenyl)-2-oxo-1,3-thiazolidine-5-carbonyl]amino]ethyl nitrate Chemical compound C1=CC(OC)=CC=C1C1C(C(=O)NCCO[N+]([O-])=O)SC(=O)N1 YFGQVZFEOCXAEE-UHFFFAOYSA-N 0.000 claims 1
- HBNQBNBZAPOSBW-UHFFFAOYSA-N 2-[[5-(4-methoxyphenyl)-2-oxo-1,3-thiazolidine-4-carbonyl]amino]ethyl nitrate Chemical compound C1=CC(OC)=CC=C1C1C(C(=O)NCCO[N+]([O-])=O)NC(=O)S1 HBNQBNBZAPOSBW-UHFFFAOYSA-N 0.000 claims 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 229910004679 ONO2 Inorganic materials 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 230000000802 nitrating effect Effects 0.000 claims 1
- 229940124549 vasodilator Drugs 0.000 claims 1
- 239000003071 vasodilator agent Substances 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000005864 Sulphur Substances 0.000 abstract 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000000304 vasodilatating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6308891 | 1991-03-27 | ||
| JP6308891 | 1991-03-27 | ||
| JP10275191 | 1991-05-08 | ||
| JP10275191 | 1991-05-08 | ||
| JP33030491 | 1991-12-13 | ||
| JP33030491 | 1991-12-13 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI921340A0 FI921340A0 (fi) | 1992-03-26 |
| FI921340L FI921340L (fi) | 1992-09-28 |
| FI106260B true FI106260B (fi) | 2000-12-29 |
Family
ID=27298042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI921340A FI106260B (fi) | 1991-03-27 | 1992-03-26 | Menetelmä verisuonia laajentavien tiatsolidinonin ja oksatsolidinonin johdannaisten valmistamiseksi |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5298516A (zh) |
| EP (1) | EP0506434B1 (zh) |
| JP (1) | JPH0780859B2 (zh) |
| KR (1) | KR0152097B1 (zh) |
| CN (2) | CN1031824C (zh) |
| AT (1) | ATE118770T1 (zh) |
| AU (1) | AU647599B2 (zh) |
| CA (1) | CA2064108C (zh) |
| CZ (1) | CZ282529B6 (zh) |
| DE (1) | DE69201451T2 (zh) |
| DK (1) | DK0506434T3 (zh) |
| ES (1) | ES2072095T3 (zh) |
| FI (1) | FI106260B (zh) |
| HK (1) | HK123595A (zh) |
| HU (2) | HU217969B (zh) |
| IE (1) | IE67383B1 (zh) |
| IL (1) | IL101395A (zh) |
| IS (1) | IS1746B (zh) |
| NO (1) | NO304311B1 (zh) |
| NZ (1) | NZ242154A (zh) |
| PH (1) | PH30493A (zh) |
| RU (1) | RU2055073C1 (zh) |
| TW (1) | TW226015B (zh) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3454531B2 (ja) * | 1991-11-07 | 2003-10-06 | 三共株式会社 | ニトロキシアルキルアミド誘導体 |
| KR960700702A (ko) * | 1993-03-15 | 1996-02-24 | 헤르베르트 서키·울리히 볼프 | 병리적으로 상승된 안내 압력을 치료하는데 치환된 알킬니트레이트를 사용하는 방법(use of substituted alkyl nitrates for the treatment of pathologically increased intraocular pressure) |
| DE4429461A1 (de) * | 1994-08-19 | 1996-02-22 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| CA2207794A1 (en) * | 1994-12-15 | 1996-06-20 | Sadao Ishihara | Thiazolidinone compounds or angina pectoris remedy or preventive containing the same as active ingredient |
| US5925658A (en) * | 1995-03-02 | 1999-07-20 | Sankyo Company, Limited | Optically active thiazolidinone derivative |
| KR100292737B1 (ko) * | 1995-03-02 | 2001-09-17 | 가와무라 요시부미 | 광학활성인티아졸리디논유도체 |
| WO1997000239A1 (fr) * | 1995-06-14 | 1997-01-03 | Sankyo Company, Limited | Medicament contre l'angine contenant un derive nitroxy comme ingredient actif |
| BE1010768A3 (nl) * | 1996-11-26 | 1999-01-05 | Dsm Nv | Een werkwijze voor de bereiding van alpha-aminozuuramiden, alpha-aminozuren en derivaten ervan. |
| IL120531A (en) * | 1997-03-26 | 2006-12-31 | Yissum Res Dev Co | Nitric oxide donors and pharmaceutical compositions containing them |
| WO2002069967A1 (fr) * | 2001-03-01 | 2002-09-12 | Sankyo Company, Limited | Compositions a absorption percutanee |
| US9457014B2 (en) * | 2011-07-28 | 2016-10-04 | Promentis Pharmaceuticals, Inc. | Cysteine prodrugs |
| US10239847B1 (en) | 2016-03-03 | 2019-03-26 | Cellactin | Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
| GB8717068D0 (en) * | 1987-07-20 | 1987-08-26 | Fujisawa Pharmaceutical Co | Nitric ester derivative |
| DK0393911T3 (da) * | 1989-04-21 | 1994-10-03 | Du Pont | Fungicide oxazolidinoner |
-
1992
- 1992-03-24 AU AU13122/92A patent/AU647599B2/en not_active Ceased
- 1992-03-24 US US07/856,491 patent/US5298516A/en not_active Expired - Fee Related
- 1992-03-25 NO NO921159A patent/NO304311B1/no not_active IP Right Cessation
- 1992-03-26 IE IE920966A patent/IE67383B1/en not_active IP Right Cessation
- 1992-03-26 CA CA002064108A patent/CA2064108C/en not_active Expired - Fee Related
- 1992-03-26 RU SU925011508A patent/RU2055073C1/ru not_active IP Right Cessation
- 1992-03-26 FI FI921340A patent/FI106260B/fi not_active IP Right Cessation
- 1992-03-26 TW TW081102328A patent/TW226015B/zh active
- 1992-03-26 IS IS3828A patent/IS1746B/is unknown
- 1992-03-26 CZ CS92916A patent/CZ282529B6/cs not_active IP Right Cessation
- 1992-03-26 JP JP4067972A patent/JPH0780859B2/ja not_active Expired - Fee Related
- 1992-03-27 AT AT92302674T patent/ATE118770T1/de not_active IP Right Cessation
- 1992-03-27 NZ NZ242154A patent/NZ242154A/xx unknown
- 1992-03-27 HU HU9201033A patent/HU217969B/hu not_active IP Right Cessation
- 1992-03-27 DE DE69201451T patent/DE69201451T2/de not_active Expired - Fee Related
- 1992-03-27 KR KR1019920005089A patent/KR0152097B1/ko not_active Expired - Fee Related
- 1992-03-27 ES ES92302674T patent/ES2072095T3/es not_active Expired - Lifetime
- 1992-03-27 EP EP92302674A patent/EP0506434B1/en not_active Expired - Lifetime
- 1992-03-27 PH PH44131A patent/PH30493A/en unknown
- 1992-03-27 CN CN92103119A patent/CN1031824C/zh not_active Expired - Fee Related
- 1992-03-27 IL IL10139592A patent/IL101395A/en not_active IP Right Cessation
- 1992-03-27 DK DK92302674.4T patent/DK0506434T3/da active
-
1993
- 1993-12-06 US US08/162,675 patent/US5356918A/en not_active Expired - Fee Related
-
1995
- 1995-05-26 CN CN95106819A patent/CN1096265C/zh not_active Expired - Fee Related
- 1995-06-29 HU HU95P/P00546P patent/HU211969A9/hu unknown
- 1995-07-27 HK HK123595A patent/HK123595A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020213376B2 (en) | Compounds and methods for the targeted degradation of the androgen receptor | |
| FI106260B (fi) | Menetelmä verisuonia laajentavien tiatsolidinonin ja oksatsolidinonin johdannaisten valmistamiseksi | |
| JP2020528918A (ja) | アンドロゲン受容体の標的化分解のための化合物および方法 | |
| WO2017176708A1 (en) | Protein-protein interaction inducing technology | |
| CA2901696C (en) | Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer | |
| KR100589544B1 (ko) | Ｐｄｆ 억제제로서의 ｎ-포르밀 히드록실아민 화합물 | |
| TW200538447A (en) | Compounds having human immunodeficiency virus protease inhibitor activity and the uses thereof | |
| KR20030025305A (ko) | 글루코겐 포스포릴라제 억제제로서의 비시클릭 피롤릴아미드 | |
| CZ62499A3 (cs) | Víceúčelové inhibitory metaloproteásy | |
| WO2005004861A1 (en) | A use of novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same | |
| US5958949A (en) | N-linked ureas and carbamates of piperidyl thioesters | |
| DE69612967T2 (de) | Optisch aktive thiazolidinonderivate | |
| HUT70561A (en) | Amino acid derivatives, pharmaceutical compns. contg. them and process to prepare the said compds. | |
| US5925658A (en) | Optically active thiazolidinone derivative | |
| CA2359031C (en) | Thiazolidinone or oxazolidinone derivatives for treatment of ulcerative disease | |
| RU2774863C2 (ru) | Соединения и способы для таргетной деградации андрогенового рецептора | |
| CZ2001798A3 (en) | Use of thia- or oxazolidinone derivatives for preparing a medicament for therapy or prevention of ulcer diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |